Processa Pharmaceuticals, Inc.

8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Jul 29, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Director or officer change Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Terminated a material agreement Feb 19, 2026 8-K Other events Jan 7, 2026 8-K Modified rights of security holders; Amended charter or bylaws Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K/A Amended charter or bylaws; Shareholder vote results Sep 16, 2025 8-K Shareholder vote results Sep 12, 2025 8-K Shareholder vote results Sep 10, 2025 8-K Shareholder vote results Sep 2, 2025 8-K Other events Aug 25, 2025 8-K/A Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 14, 2025 8-K Delisting notice or listing-rule failure Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 7, 2025 8-K Other events Jul 25, 2025 8-K Shareholder vote results Jul 18, 2025 8-K Shareholder vote results Jul 15, 2025 8-K Entered a material agreement; Regulation FD disclosure Jul 1, 2025 8-K Entered a material agreement; Shareholder vote results Jun 30, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 18, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Regulation FD disclosure Feb 11, 2025 8-K Delisting notice or listing-rule failure Feb 10, 2025 8-K Entered a material agreement; Regulation FD disclosure Jan 30, 2025 8-K Changed accountants Nov 6, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Other events Oct 2, 2024 8-K Other events Aug 28, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Other events Jul 30, 2024 8-K Director or officer change; Regulation FD disclosure Jul 17, 2024 8-K Shareholder vote results Jul 2, 2024 8-K Entered a material agreement May 21, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024